Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-15

FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for methimazole from Chartwell RX, LLC, marking a supplemental approval for this generic antithyroid medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methimazole (Methimazole)

Snippet

SUPPL AP for METHIMAZOLE (METHIMAZOLE)